{"publish_date":{"3113422":20140602,"3116173":20140602,"3114490":20140602},"url":{"3113422":"http:\/\/www.thelancet.com\/journals\/lanres\/article\/PIIS2213-2600(14)70128-6\/fulltext","3116173":"http:\/\/www.xconomy.com\/wisconsin\/2014\/06\/02\/wi-based-flugen-raises-3-4m-for-universal-flu-vaccine-phase-i-trial\/","3114490":"http:\/\/www.trust.org\/item\/20140602114055-xv0dy\/?source=fiTheWire&c=_ot4k0AOldDm8IT5K4GOp4rOih6Iily-KiTlgyWItOM&mkt=en-us"},"topic":{"3113422":"influ","3116173":"influ","3114490":"influ"},"model1_prediction":{"3113422":1,"3116173":1,"3114490":1},"model1_prediction_prob":{"3113422":0.6544584675,"3116173":0.6173178533,"3114490":0.5710806884},"title":{"3113422":"Further evidence for the effectiveness of PCV10 against Streptococcus pneumoniae serotype 19A","3116173":"WI-based FluGen Raises $3.4M For Universal Flu Vaccine Phase I Trial","3114490":"Locally made vaccines \u2018could boost immunisation efforts\u2019"}}